Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 May 2024
Retrospective study finds that the 5-year OS rate for early HCC nearly doubled when compared to nonsurgical approaches.
Read Full NewsNeurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.
A man with a prior below-knee amputation develops progressive stump pain, and vascular imaging reveals an unexpected arterial blockage that is still treatable.
What belongs to medicine, and what belongs to the machine? Dr Travis Bias argues that AI must augment — not replace — human connection in clinical care.
Dr Lily Brown explains why GAD is often underdiagnosed and how overreliance on depression labels and the GAD-7 alone can miss key anxiety disorders.
Dr Raghda Rashad argues that screening for occupational history could keep more women in the workforce, but most clinicians never ask.
Extreme heat is already increasing deaths, worsening chronic diseases, and widening health inequalities, as clinicians face growing pressure to prepare for a hotter future.
The Ebola outbreak in Congo has not yet stabilised and is still expanding as population movement fuels transmission, a World Health Organization official said on...
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
Resection for Early Liver Cancer Tied to Improved Survival.
3.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
4.
An individual state lost $4.02 billion due to untreated mental illness.
5.
Medical Journal March 29, 2023
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
3.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
4.
National Blood Health Promotion Strategies: Evidence-Based Approaches for Improved Outcomes
5.
The Science Behind Thrombolytic Drugs and Their Benefits
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge